Fly On The Wall : CANTOR MAINTAINS BUY RATING, RAISES TARGET TO $16. (( LINK ))
FLY ON THE WALL 3/8/13
March 8, 2013
07:50 EDT CLDX Celldex price target raised to $16 from $13 at Cantor
Cantor increased its price target on Celldex as the firm now expects the company to begin obtaining revenues from both CDX-011 and rindopepimut in 2016 versus its original forecast of 2017. The firm maintains a Buy rating on the stock.